EcoDrugPlus


Trade Names	VENOFER
Synonyms	Ferric hydroxide sucrose complex Iron oxide saccharated Iron saccharate Iron sucrose Iron sucrose complex Iron sugar Iron(iii) hydroxide sucrose complex Saccharated ferric oxide Saccharated iron Saccharated iron oxide Venofer XI-921
Status
Molecule Category	UNKNOWN
UNII	FZ7NYF5N8L

Trade Names

VENOFER

Synonyms

Ferric hydroxide sucrose complex

Iron oxide saccharated

Iron saccharate

Iron sucrose

Iron sucrose complex

Iron sugar

Iron(iii) hydroxide sucrose complex

Saccharated ferric oxide

Saccharated iron

Saccharated iron oxide

Venofer

XI-921

Status

Molecule Category

UNKNOWN

UNII

FZ7NYF5N8L


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C12H22FeO11
Molecular Weight	398.14
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C12H22FeO11

Molecular Weight

398.14

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Resources	Reference
ChEMBL	CHEMBL1200823
FDA SRS	FZ7NYF5N8L
PubChem	91663255

Resources

Reference

ChEMBL

CHEMBL1200823

FDA SRS

FZ7NYF5N8L

PubChem

91663255


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

IRON SUCROSE

Physicochemical Descriptors

Cross References